Cite Filings / KLRS / 0000950170-24-092175
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
144

Sale of Securities

Kalaris Therapeutics, Inc. · Filed 2024-08-06 · Acc 0000950170-24-092175

Documents 1

  • 144 Sale of Securities , xsl144X01/primary_doc.xml

Around this filing

  • 2024-08-07 4 General Counsel sold 2,323 shares at $0.73 ($1,707)
  • 2024-08-07 4 Chief Executive Officer sold 10,847 shares at $0.73 ($7,970)
  • 2024-08-07 4 Chief Accounting Officer sold 1,692 shares at $0.73 ($1,243)
  • 2024-08-06 144 Sale of Securities
  • 2024-08-06 144 Sale of Securities
  • 2024-08-06 144 Sale of Securities
  • 2024-08-06 144 Sale of Securities

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
Loading xsl144X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…